Psoriasis Treatment Market

Psoriasis Treatment Market - Global Industry
Insights, Trends, Outlook, and Opportunity Analysis,
2018-2026
Psoriasis is a non-communicable autoimmune disease characterized by patches of abnormal
skin. These skin spots are red, itchy, and scaly which may be small and localized or cover the
entire body. Skin injury may cause psoriatic skin changes at that spot, a phenomenon called
Koebner phenomenon.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/99
There are five main types of psoriasis namely Plaque, Guttate, Inverse, Pustular,
and Erythrodermic. Plaque psoriasis, also known as psoriasis vulgaris, is the most prevalent
type of psoriasis, accounting for around 90% of reported cases. Most commonly affected areas
of the body include back of the forearms, shins, around the navel, and the scalp. Guttate
psoriasis has drop-shaped lesions. Pustular psoriasis is characterized by the presence of small
non-infectious pus-filled blisters. Inverse psoriasis forms red patches in skin folds. Erythrodermic
psoriasis occurs when the rash become widespread and can develop from other
types. Fingernails and toenails are affected in most people at some point of time. This may
include pits in the nails or changes in nail color.
Treatment options for Psoriasis fueling growth of the psoriasis treatment market
Various treatments can help control the symptoms fueling growth of psoriasis treatment
market. These treatment methods include administering steroid, vitamin D3, exposure to
ultraviolet B (UVB) light, and immunosuppressive like methotrexate. Around 75% of cases can
be managed with creams alone. Cream and ointments of corticosteroid, and calcipotriol can
effectively treat mild-to-moderate psoriasis. However, when condition become more severe,
creams are combined with oral medications such as methotrexate, acitretin, and cyclosporin.
Topical drugs used in treatment of psoriasis include corticosteroids, vitamin D,
hydroxyanthrone, and retinoid aiding in growth of the psoriasis treatment market. Topical
corticosteroids are frequently prescribed for treating mild-to-moderate psoriasis. Low-potency
corticosteroid ointments are recommended for sensitive areas such as face or skin folds and for
treating widespread patches of damaged skin. Medicated foams and scalp solutions are available
in market to treat psoriasis patches on the scalp. Vitamin D analogues are synthetic forms of
vitamin D and they slow the growth of skin cells. Calcipotriene (Dovonex) is a cream or
solution a vitamin D that contains analogue, used by itself to treat mild-to-moderate psoriasis
or in combination with other topical medications. Anthralin (Hydroxyanthrone) is used to
normalize DNA activity in skin cells. Anthralin (Dritho-Scalp) also can remove scale, making the
skin smoother. Topical retinoids normalizes DNA activity in skin cells and decreases
inflammation.
Report includes chapters which deeply display the following deliverable about industry :
• Psoriasis Treatment Market Research Objective and Assumption
• Psoriasis Treatment Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Psoriasis Treatment Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Psoriasis Treatment Market, By Regions
• Psoriasis Treatment Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Psoriasis Treatment Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Psoriasis Treatment Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Psoriasis Treatment Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Light Therapy (Phototherapy) for psoriasis treatment
This psoriasis treatment involves use of natural or artificial ultraviolet light. Phototherapy
involves exposing skin to controlled amounts of natural sunlight. Other forms of light therapy
include use of artificial ultraviolet A (UVA) or ultraviolet B (UVB) light either alone or in
combination with medications.
Increasing prevalence of psoriasis coupled with early diagnosis to propel growth of psoriasis
treatment market
The growth of psoriasis treatment market is projected to gain traction in North America owing
to large patient pool in this region. Also, better medical facilities, commercialization of new
diagnostic technology, medical policies, and favorable reimbursement policies are factors fueling
growth of psoriasis treatment market. According to the International Federation of Psoriasis
Associations (IFPA), around 3% of the world’s population has some form of psoriasis. According
to a study published in Cleveland Clinic in September 2013, there are around 150,000 new
cases of psoriasis reported each year in the U.S. According to a study published in Medical
Journal of Malaysia, in 2015 prevalence of psoriasis varies between 2.0% to 3.0% worldwide.
Incidence rate is highest among Caucasians and lowest among Japanese and Africans. The study
states that prevalence rate of psoriasis in Japan is 0.05% to 0.1%, as compared to China 0.5%
and Taiwan 0.2%, and in India, the prevalence of psoriasis was reported in the range of 0.4%
to 2.8%. High prevalence and increasing incidence propels growth of the psoriasis treatment
market.
Browse Complete Report For More Information @ http://bit.ly/324IpfB
Key players involved in psoriasis treatment market
There are many global players operating in the global psoriasis treatment market. This includes
Glenmark Pharmaceuticals Limited, Sun Pharmaceuticals Industries Ltd., Cipla Ltd., Johnson &
Johnson, Rowan Bioceuticals Private Limited, Stiefel Laboratories Inc. (GlaxoSmithKline plc),
Win Medicare Pvt. Ltd., and Novartis AG. Novartis AG acquired Ziarco Pharma Ltd— a U.K.based dermatology therapeutics firm—in December 2016 to acquire a pipeline of oral and
topical products for treatment of psoriasis. Acquisition of the potentially first-in-class therapy
would bolster dermatology portfolio and pipeline of Novartis. Ziarco completed Phase II trial, a
proof-of-concept study with ZPL-389.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Psoriasis is a non-communicable autoimmune disease characterized by patches of abnormal skin.

Download Report